特鲁纳特对尼日利亚结核病诊断的影响
R Eneogu1, J Olabamiji2, A Ihesie1
1HIV AIDS & TB Office, USAID Nigeria, Abuja.
Public health action
|September 6, 2024
概括
特鲁纳特试验显著改善了尼日利亚边缘设施的结核病 (TB) 诊断和治疗开始时间. 这一进步有助于发现更多的结核病和耐药结核病 (DR-TB) 病例.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 传染病研究 传染病研究
- 公共卫生干预措施 公共卫生干预措施
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,特别是在资源有限的环境中.
- 边缘医疗保健机构经常面临诊断延迟,影响患者的治疗结果和疾病控制.
- 引入快速诊断工具对于改善结核病例检测和管理至关重要.
研究的目的:
- 评估Truenat对结核病诊断的影响.
- 评估结核病诊断和治疗启动对周转时间 (TAT) 的影响.
- 确定Truenat在增加结核病和耐药结核病 (DR-TB) 病例检测中的作用.
主要方法:
- 在34个尼日利亚边缘设施中进行了一项回顾性横截面研究,这些设施实施了Truenat.
- 收集了关于诊断回归时间和治疗开始时间的数据.
- 对结核病例报告的趋势进行了Truenat实施前后的比较.
主要成果:
- 结核病诊断的中位时间不到24小时,57.9%的结核病患者在这段时间内被诊断出结核病.
- 开始治疗的中位时间为1.5天.
- 结核病和DR-TB病例的检测增加,在Truenat实施期间发现的阳性病例比例更高.
结论:
- 在尼日利亚的边缘设施中,Truenat测试的部署提高了结核病和DR-TB病例的检测.
- 该试验缩短了诊断周转时间,加快了治疗的开始.
- 特鲁纳特是识别失踪结核病例和改善结核病控制工作的宝贵工具.
相关概念视频
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215


